Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard Log In Required
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Statements Log In Required
    • Statements
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Financial Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
    • Charitable Giving
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook
    • Notebook
  • Investment Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Crypto
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Cash Management & Credit Cards
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance & Long Term Care
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
Content and data provided by various third parties and Fidelity − Terms of Use
  • Research >
  • Stocks >
  • News & Events >

Stock Details


  • Snapshot
  • Detailed Quote
  • Advanced Chart &
    Technical Analysis Opens in New Window
  • News & Events
  • Compare
  • Analyst Opinions
  • Research Reports
  • Key Statistics
  • Earnings
  • Dividends
  • Ownership & Insiders
  • Financial Statements
  • SEC Filings

RELATED RESOURCES

  • Stock Research Overview
  • Stock Screeners
  • Markets & Sectors
  • Fidelity Learning Center Opens in New Window
Print Format
Change Text Size:
  • Default text sizeA
  • Larger text sizeA
  • Largest text sizeA

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022

BY Benzinga
— 10:04 AM ET 05/24/2022

Upgrades

Susquehanna upgraded the previous rating for Lattice Semiconductor Corp NASDAQ:LSCC from Neutral to Positive. In the first quarter, Lattice Semiconductor showed an EPS of $0.37, compared to $0.22 from the year-ago quarter. The current stock performance of Lattice Semiconductor shows a 52-week-high of $85.45 and a 52-week-low of $43.59. Moreover, at the end of the last trading period, the closing price was at $48.82.

According to Barclays, the prior rating for Otis Worldwide Corp NYSE:OTIS was changed from Equal-Weight to Overweight. In the first quarter, Otis Worldwide showed an EPS of $0.77, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $92.84 and a 52-week-low of $71.07. At the end of the last trading period, Otis Worldwide closed at $73.87.

B of A Securities upgraded the previous rating for Northwest Natural Holding Co NYSE:NWN from Underperform to Neutral. Northwest Natural Hldg earned $1.80 in the first quarter, compared to $1.94 in the year-ago quarter. The stock has a 52-week-high of $57.63 and a 52-week-low of $43.07. At the end of the last trading period, Northwest Natural Hldg closed at $52.48.

According to Morgan Stanley, the prior rating for Marqeta Inc NASDAQ:MQ was changed from Equal-Weight to Overweight. The stock has a 52-week-high of $37.90 and a 52-week-low of $6.05. At the end of the last trading period, Marqeta closed at $9.73.

For Snowflake Inc NYSE:SNOW, Rosenblatt upgraded the previous rating of Neutral to Buy. For the fourth quarter, Snowflake had an EPS of $0.12, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $405.00 and a 52-week-low of $126.01. At the end of the last trading period, Snowflake closed at $138.85.

See all analyst ratings upgrades.

Downgrades

For CynergisTek Inc AMEX:CTEK, Craig-Hallum downgraded the previous rating of Buy to Hold. For the first quarter, CynergisTek had an EPS of $0.07, compared to year-ago quarter EPS of $0.08. The current stock performance of CynergisTek shows a 52-week-high of $2.85 and a 52-week-low of $0.58. Moreover, at the end of the last trading period, the closing price was at $0.59.

According to Stephens & Co., the prior rating for OncoCyte Corp NASDAQ:OCX was changed from Overweight to Equal-Weight. OncoCyte earned $0.11 in the first quarter, compared to $0.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.25 and a 52-week-low of $1.07. OncoCyte closed at $1.08 at the end of the last trading period.

According to B. Riley Securities, the prior rating for INmune Bio Inc NASDAQ:INMB was changed from Buy to Neutral. INmune Bio earned $0.39 in the first quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $30.37 and a 52-week-low of $6.18. At the end of the last trading period, INmune Bio closed at $7.27.

According to Barclays, the prior rating for Eaton Corp PLC NYSE:ETN was changed from Equal-Weight to Underweight. Eaton Corp earned $1.62 in the first quarter, compared to $1.44 in the year-ago quarter. The stock has a 52-week-high of $175.72 and a 52-week-low of $132.16. At the end of the last trading period, Eaton Corp closed at $136.76.

For Nautilus Inc NYSE:NLS, Craig-Hallum downgraded the previous rating of Buy to Hold. Nautilus earned $0.58 in the fourth quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of $18.58 and a 52-week-low of $2.34. At the end of the last trading period, Nautilus closed at $2.51.

For Switch Inc NYSE:SWCH, Berenberg downgraded the previous rating of Buy to Hold. Switch earned $0.04 in the first quarter, compared to $0.08 in the year-ago quarter. The current stock performance of Switch shows a 52-week-high of $33.84 and a 52-week-low of $18.39. Moreover, at the end of the last trading period, the closing price was at $33.37.

For Roblox Corp NYSE:RBLX, Atlantic Equities downgraded the previous rating of Overweight to Neutral. For the first quarter, Roblox had an EPS of $0.27, compared to year-ago quarter EPS of $0.46. The current stock performance of Roblox shows a 52-week-high of $141.60 and a 52-week-low of $21.65. Moreover, at the end of the last trading period, the closing price was at $30.06.

According to Keybanc, the prior rating for WalkMe Ltd NASDAQ:WKME was changed from Overweight to Sector Weight. WalkMe earned $0.22 in the first quarter, compared to $0.13 in the year-ago quarter. The current stock performance of WalkMe shows a 52-week-high of $34.42 and a 52-week-low of $11.40. Moreover, at the end of the last trading period, the closing price was at $12.20.

See all analyst ratings downgrades.

Initiations

Citigroup initiated coverage on Unum Group NYSE:UNM with a Neutral rating. For the first quarter, Unum had an EPS of $1.36, compared to year-ago quarter EPS of $1.04. The stock has a 52-week-high of $36.73 and a 52-week-low of $22.25. At the end of the last trading period, Unum closed at $35.18.

With a Buy rating, Lake Street initiated coverage on Winc Inc AMEX:WBEV. The price target seems to have been set at $6.00 for Winc. The stock has a 52-week-high of $8.66 and a 52-week-low of $2.01. At the end of the last trading period, Winc closed at $2.17.

Citigroup initiated coverage on Voya Financial Inc NYSE:VOYA with a Buy rating. The price target for Voya Financial is set to $82.00. For the first quarter, Voya Financial had an EPS of $1.47, compared to year-ago quarter EPS of $1.03. The stock has a 52-week-high of $74.97 and a 52-week-low of $58.97. At the end of the last trading period, Voya Financial closed at $64.93.

DA Davidson initiated coverage on ITHAX Acquisition Corp NASDAQ:ITHX with a Buy rating. The price target for ITHAX Acquisition is set to $13.50. The stock has a 52-week-high of $10.30 and a 52-week-low of $9.60. At the end of the last trading period, ITHAX Acquisition closed at $9.80.

With a Buy rating, CL King initiated coverage on The Hain Celestial Group Inc NASDAQ:HAIN. The price target seems to have been set at $35.00 for Hain Celestial Group. For the third quarter, Hain Celestial Group had an EPS of $0.33, compared to year-ago quarter EPS of $0.44. The current stock performance of Hain Celestial Group shows a 52-week-high of $48.88 and a 52-week-low of $24.11. Moreover, at the end of the last trading period, the closing price was at $24.91.

Guggenheim initiated coverage on HilleVax Inc NASDAQ:HLVX with a Buy rating. The price target for HilleVax is set to $40.00. The current stock performance of HilleVax shows a 52-week-high of $20.95 and a 52-week-low of $9.00. Moreover, at the end of the last trading period, the closing price was at $9.50.

Cantor Fitzgerald initiated coverage on Lyra Therapeutics Inc NASDAQ:LYRA with an Overweight rating. The price target for Lyra Therapeutics is set to $15.00. Lyra Therapeutics earned $0.54 in the first quarter, compared to $0.60 in the year-ago quarter. The current stock performance of Lyra Therapeutics shows a 52-week-high of $9.98 and a 52-week-low of $3.30. Moreover, at the end of the last trading period, the closing price was at $6.07.

SVB Leerink initiated coverage on HilleVax Inc NASDAQ:HLVX with an Outperform rating. The price target for HilleVax is set to $30.00. At the moment, the stock has a 52-week-high of $20.95 and a 52-week-low of $9.00. HilleVax closed at $9.50 at the end of the last trading period.

With a Neutral rating, Colliers Securities initiated coverage on INDUS Realty Trust Inc NASDAQ:INDT. The price target seems to have been set at $70.00 for INDUS Realty Trust. For the first quarter, INDUS Realty Trust had an EPS of $0.38, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $82.94 and a 52-week-low of $61.36. INDUS Realty Trust closed at $63.19 at the end of the last trading period.

With an Overweight rating, JP Morgan initiated coverage on HilleVax Inc NASDAQ:HLVX. The price target seems to have been set at $24.00 for HilleVax. The current stock performance of HilleVax shows a 52-week-high of $20.95 and a 52-week-low of $9.00. Moreover, at the end of the last trading period, the closing price was at $9.50.

Citigroup initiated coverage on The Travelers Companies Inc NYSE:TRV with a Neutral rating. The price target for Travelers Companies is set to $179.00. For the first quarter, Travelers Companies had an EPS of $4.22, compared to year-ago quarter EPS of $2.73. The stock has a 52-week-high of $187.98 and a 52-week-low of $144.44. At the end of the last trading period, Travelers Companies closed at $172.10.

With a Sell rating, Citigroup initiated coverage on Reinsurance Group of America Inc NYSE:RGA. The price target seems to have been set at $110.00 for Reinsurance Group. For the first quarter, Reinsurance Group had an EPS of $0.47, compared to year-ago quarter EPS of $1.24. The stock has a 52-week-high of $128.93 and a 52-week-low of $94.32. At the end of the last trading period, Reinsurance Group closed at $121.74.

Citigroup initiated coverage on Prudential Financial Inc NYSE:PRU with a Neutral rating. The price target for Prudential Financial is set to $100.00. For the first quarter, Prudential Financial had an EPS of $3.17, compared to year-ago quarter EPS of $4.11. At the moment, the stock has a 52-week-high of $124.22 and a 52-week-low of $94.51. Prudential Financial closed at $101.40 at the end of the last trading period.

With a Buy rating, Stifel initiated coverage on HilleVax Inc NASDAQ:HLVX. The price target seems to have been set at $34.00 for HilleVax. At the moment, the stock has a 52-week-high of $20.95 and a 52-week-low of $9.00. HilleVax closed at $9.50 at the end of the last trading period.

With a Sell rating, Citigroup initiated coverage on Principal Financial Group Inc NASDAQ:PFG. The price target seems to have been set at $63.00 for Principal Finl Gr. For the first quarter, Principal Finl Gr had an EPS of $1.63, compared to year-ago quarter EPS of $1.53. The stock has a 52-week-high of $80.36 and a 52-week-low of $58.66. At the end of the last trading period, Principal Finl Gr closed at $70.53.

With a Buy rating, Citigroup initiated coverage on MetLife Inc NYSE:MET. The price target seems to have been set at $77.00 for MetLife. MetLife earned $2.08 in the first quarter, compared to $2.20 in the year-ago quarter. The current stock performance of MetLife shows a 52-week-high of $73.18 and a 52-week-low of $55.21. Moreover, at the end of the last trading period, the closing price was at $63.95.

Citigroup initiated coverage on Lincoln National Corp NYSE:LNC with a Neutral rating. The price target for Lincoln National is set to $56.00. In the first quarter, Lincoln National showed an EPS of $1.66, compared to $1.82 from the year-ago quarter. The current stock performance of Lincoln National shows a 52-week-high of $77.57 and a 52-week-low of $50.55. Moreover, at the end of the last trading period, the closing price was at $54.03.

With a Buy rating, HC Wainwright & Co. initiated coverage on Tanzanian Gold Corp AMEX:TRX. The price target seems to have been set at $0.70 for Tanzanian Gold. The current stock performance of Tanzanian Gold shows a 52-week-high of $0.60 and a 52-week-low of $0.26. Moreover, at the end of the last trading period, the closing price was at $0.32.

Citigroup initiated coverage on The Hartford Financial Services Group Inc NYSE:HIG with a Buy rating. The price target for Hartford Finl Servs Gr is set to $81.00. In the first quarter, Hartford Finl Servs Gr showed an EPS of $1.66, compared to $0.56 from the year-ago quarter. The current stock performance of Hartford Finl Servs Gr shows a 52-week-high of $78.17 and a 52-week-low of $59.86. Moreover, at the end of the last trading period, the closing price was at $68.63.

Citigroup initiated coverage on Equitable Holdings Inc NYSE:EQH with a Buy rating. The price target for Equitable Holdings is set to $41.00. In the first quarter, Equitable Holdings showed an EPS of $1.53, compared to $1.35 from the year-ago quarter. The stock has a 52-week-high of $37.13 and a 52-week-low of $25.73. At the end of the last trading period, Equitable Holdings closed at $28.79.

Citigroup initiated coverage on Chubb Ltd NYSE:CB with a Neutral rating. The price target for Chubb is set to $209.00. Chubb earned $3.82 in the first quarter, compared to $2.52 in the year-ago quarter. The stock has a 52-week-high of $218.99 and a 52-week-low of $155.78. At the end of the last trading period, Chubb closed at $207.31.

Citigroup initiated coverage on Allstate Corp NYSE:ALL with a Buy rating. The price target for Allstate is set to $159.00. For the first quarter, Allstate had an EPS of $2.58, compared to year-ago quarter EPS of $6.11. At the moment, the stock has a 52-week-high of $144.46 and a 52-week-low of $106.11. Allstate closed at $125.66 at the end of the last trading period.

Citigroup initiated coverage on Aflac Inc NYSE:AFL with a Neutral rating. The price target for Aflac is set to $60.00. For the first quarter, Aflac had an EPS of $1.42, compared to year-ago quarter EPS of $1.53. At the moment, the stock has a 52-week-high of $67.20 and a 52-week-low of $51.28. Aflac closed at $56.53 at the end of the last trading period.

With a Sell rating, Citigroup initiated coverage on Progressive Corp NYSE:PGR. The price target seems to have been set at $93.00 for Progressive. Progressive earned $1.11 in the first quarter, compared to $1.73 in the year-ago quarter. The current stock performance of Progressive shows a 52-week-high of $120.17 and a 52-week-low of $89.35. Moreover, at the end of the last trading period, the closing price was at $112.94.

With a Buy rating, Rosenblatt initiated coverage on Imax Corp NYSE:IMAX. The price target seems to have been set at $25.00 for Imax. Imax earned $0.14 in the first quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $23.57 and a 52-week-low of $13.60. At the end of the last trading period, Imax closed at $15.68.

With a Buy rating, Rosenblatt initiated coverage on Harmonic Inc NASDAQ:HLIT. The price target seems to have been set at $15.00 for Harmonic. In the first quarter, Harmonic showed an EPS of $0.08, compared to $0.04 from the year-ago quarter. The current stock performance of Harmonic shows a 52-week-high of $12.22 and a 52-week-low of $6.69. Moreover, at the end of the last trading period, the closing price was at $9.27.

With a Buy rating, Rosenblatt initiated coverage on Dolby Laboratories Inc NYSE:DLB. The price target seems to have been set at $90.00 for Dolby Laboratories. In the second quarter, Dolby Laboratories showed an EPS of $0.92, compared to $0.91 from the year-ago quarter. The current stock performance of Dolby Laboratories shows a 52-week-high of $104.25 and a 52-week-low of $69.18. Moreover, at the end of the last trading period, the closing price was at $75.34.

Guggenheim initiated coverage on Syneos Health Inc NASDAQ:SYNH with a Buy rating. The price target for Syneos Health is set to $81.00. Syneos Health earned $1.01 in the first quarter, compared to $0.79 in the year-ago quarter. The current stock performance of Syneos Health shows a 52-week-high of $104.18 and a 52-week-low of $66.73. Moreover, at the end of the last trading period, the closing price was at $71.47.

Guggenheim initiated coverage on Medpace Holdings Inc NASDAQ:MEDP with a Neutral rating. Medpace Hldgs earned $1.69 in the first quarter, compared to $1.14 in the year-ago quarter. The stock has a 52-week-high of $231.00 and a 52-week-low of $126.94. At the end of the last trading period, Medpace Hldgs closed at $133.72.

Guggenheim initiated coverage on IQVIA Holdings Inc NYSE:IQV with a Buy rating. The price target for IQVIA Hldgs is set to $244.00. For the first quarter, IQVIA Hldgs had an EPS of $2.47, compared to year-ago quarter EPS of $2.18. The stock has a 52-week-high of $285.61 and a 52-week-low of $195.57. At the end of the last trading period, IQVIA Hldgs closed at $203.39.

With a Buy rating, Guggenheim initiated coverage on Icon PLC NASDAQ:ICLR. The price target seems to have been set at $285.00 for Icon. In the first quarter, Icon showed an EPS of $2.76, compared to $2.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $313.00 and a 52-week-low of $199.01. Icon closed at $217.58 at the end of the last trading period.

For Charles River Laboratories International Inc NYSE:CRL, Guggenheim initiated coverage, by setting the current rating at Neutral. For the first quarter, Charles River had an EPS of $2.75, compared to year-ago quarter EPS of $2.53. At the moment, the stock has a 52-week-high of $460.21 and a 52-week-low of $217.19. Charles River closed at $231.24 at the end of the last trading period.

With a Market Perform rating, Bernstein initiated coverage on eBay Inc NASDAQ:EBAY. The price target seems to have been set at $50.00 for eBay. In the first quarter, eBay showed an EPS of $1.05, compared to $1.09 from the year-ago quarter. The current stock performance of eBay shows a 52-week-high of $81.19 and a 52-week-low of $43.28. Moreover, at the end of the last trading period, the closing price was at $45.19.

Bernstein initiated coverage on Wayfair Inc NYSE:W with an Underperform rating. The price target for Wayfair is set to $45.00. In the first quarter, Wayfair showed an EPS of $1.96, compared to $1.00 from the year-ago quarter. The stock has a 52-week-high of $339.56 and a 52-week-low of $46.66. At the end of the last trading period, Wayfair closed at $50.22.

With an Underperform rating, Bernstein initiated coverage on Zillow Group Inc NASDAQ:ZG. The price target seems to have been set at $34.00 for Zillow Gr. Zillow Gr earned $0.49 in the first quarter, compared to $0.44 in the year-ago quarter. At the moment, the stock has a 52-week-high of $124.90 and a 52-week-low of $33.26. Zillow Gr closed at $40.92 at the end of the last trading period.

With an Outperform rating, Bernstein initiated coverage on DoorDash Inc NYSE:DASH. The price target seems to have been set at $90.00 for DoorDash. In the first quarter, DoorDash showed an EPS of $0.48, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of $257.25 and a 52-week-low of $57.60. At the end of the last trading period, DoorDash closed at $67.81.

With an Outperform rating, Bernstein initiated coverage on Etsy Inc NASDAQ:ETSY. The price target seems to have been set at $105.00 for Etsy. For the first quarter, Etsy had an EPS of $0.60, compared to year-ago quarter EPS of $1.00. The stock has a 52-week-high of $307.75 and a 52-week-low of $72.66. At the end of the last trading period, Etsy closed at $76.07.

SVB Leerink initiated coverage on Horizon Therapeutics PLC NASDAQ:HZNP with a Market Perform rating. The price target for Horizon Therapeutics is set to $95.00. In the first quarter, Horizon Therapeutics showed an EPS of $1.34, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $120.53 and a 52-week-low of $82.51. At the end of the last trading period, Horizon Therapeutics closed at $87.38.

See all analyst ratings initiations.

More HZNP News

  • Horizon Therapeutics plc to Present MIRROR Randomized Controlled Trial Primary Endpoint Data at The EULAR 2022 European Congress of Rheumatology
    Business Wire - 8:00 AM ET 05/24/2022
  • Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
    Benzinga - 10:33 AM ET 05/23/2022
  • 4 Analysts Have This to Say About Horizon Therapeutics
    Benzinga - 9:05 AM ET 05/23/2022
Fidelity Investments. Copyright 1998–2022 FMR LLC. 
All rights reserved. 

  • Terms of Use|
  • Privacy|
  • Security|
  • Site Map 
Close